These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17940837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F, Kato T, Tokita H, Izumi N, Kato M, Yuen MF, Lai CL, Gish RG, Ueda R, Mizokami M.
    Clin Infect Dis; 2006 Jan 01; 42(1):1-7. PubMed ID: 16323084
    [Abstract] [Full Text] [Related]

  • 3. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
    Kim JK, Chang HY, Lee JM, Baatarkhuu O, Yoon YJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH.
    J Med Virol; 2009 Jun 01; 81(6):1002-8. PubMed ID: 19382267
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
    Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG.
    Liver Int; 2007 Dec 01; 27(10):1356-63. PubMed ID: 17900245
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL, Kao JH.
    J Biomed Sci; 2008 Mar 01; 15(2):137-45. PubMed ID: 18058038
    [Abstract] [Full Text] [Related]

  • 10. Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.
    Lyu H, Lee D, Chung YH, Kim JA, Lee JH, Jin YJ, Park W, Mathews P, Jaffee E, Zheng L, Yu E, Lee YJ.
    J Viral Hepat; 2013 Mar 01; 20(3):219-24. PubMed ID: 23383661
    [Abstract] [Full Text] [Related]

  • 11. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar 01; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 12. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Gastroenterology; 2007 Nov 01; 133(5):1466-74. PubMed ID: 17915220
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF.
    World J Gastroenterol; 2016 Sep 21; 22(35):8041-9. PubMed ID: 27672298
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.
    Tatsukawa M, Takaki A, Shiraha H, Koike K, Iwasaki Y, Kobashi H, Fujioka S, Sakaguchi K, Yamamoto K.
    BMC Cancer; 2011 Oct 21; 11():458. PubMed ID: 22014121
    [Abstract] [Full Text] [Related]

  • 20. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
    Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, Lai CL, Ueda R, Mizokami M.
    J Hepatol; 2006 Nov 21; 45(5):646-53. PubMed ID: 16935384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.